Skip to main content
14 August 2026
06 June 2025

bitBiome Strengthens Biomanufacturing Pipeline Through Strategic Partnership

bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes to power the future of the bioeconomy, announced a new partnership that will enable large-scale enzyme, protein and ingredient manufacture.  This partnership ensures that bitBiome is a fully integrated front- and back-end company,…

02 June 2025

Sanofi to Acquire Blueprint Medicines, Expanding Immunology Pipeline

Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other KIT-driven diseases, have entered into an agreement under which Sanofi will acquire Blueprint. The acquisition includes a ra…

30 May 2025

Mapmygenome Acquires Microbiome Insights to Drive Global Expansion

Mapmygenome, an AI-driven leader in genomics and personalized health, announced the strategic acquisition of Microbiome Insights, a global leader in microbial sequencing. The acquisition includes Microbiome Insights' CAP-accredited Canadian laboratory and rich intellectual property, boosting Mapmygenome's scientific p…

28 May 2025

BioIVT and Handok Biotech Partner to Drive Biotech Innovation in South Korea

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced an exclusive commercial agreement with Handok Biotech Co. LTD., which will allow Handok to offer researchers in South Korea access to a wider range of high-quality, innovative products. The strategic all…

Page 34 of 37